Cargando…

The effects of BRCA1 expression on the chemosensitivity of gastric cancer cells to platinum agents

Breast cancer type 1 susceptibility protein (BRCA1) is a tumor suppressor gene that encodes a nuclear phosphoprotein, which is involved in homologous recombination to repair DNA double strand breaks and maintain genome stability. When BRCA1 is mutated or altered, DNA damage may not be effectively re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Geon, Kim, Jisu, Han, Su-Young, Hwang, In Gyu, Kim, Hee Sung, Min, Hyeyoung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507359/ https://www.ncbi.nlm.nih.gov/pubmed/31186713 http://dx.doi.org/10.3892/ol.2019.10169

Ejemplares similares

Clinical significance of BRCA1 and BRCA2 mRNA and protein expression in patients with sporadic gastric cancer
por: Kim, Hee Sung, et al.
Publicado: (2019)

BRCA-mutated gastric adenocarcinomas are associated with chromosomal instability and responsiveness to platinum-based chemotherapy
por: Oh, Ji Hyun, et al.
Publicado: (2023)

The effects of ERCC1 expression levels on the chemosensitivity of gastric cancer cells to platinum agents and survival in gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy
por: LIU, YONG-PING, et al.
Publicado: (2013)

Ginseng for an eye: effects of ginseng on ocular diseases
por: Kim, Jisu, et al.
Publicado: (2020)

Low PARP-1 expression level is an indicator of poor prognosis in patients with stage II and III gastric cancer
por: Park, Song Ee, et al.
Publicado: (2022)

Docosahexaenoic Acid Induces Oxidative DNA Damage and Apoptosis, and Enhances the Chemosensitivity of Cancer Cells
por: Song, Eun Ah, et al.
Publicado: (2016)

BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells
por: Tassone, P, et al.
Publicado: (2003)

Establishment of chemosensitivity tests in triple-negative and BRCA-mutated breast cancer patient-derived xenograft models
por: Park, Hyung Seok, et al.
Publicado: (2019)

DOCK4 Is a Platinum-Chemosensitive and Prognostic-Related Biomarker in Ovarian Cancer
por: Zhao, Qianqian, et al.
Publicado: (2021)

Molecular basis of chemosensitivity of platinum pre-treated ovarian cancer to chemotherapy
por: Glaysher, S, et al.
Publicado: (2010)

Chemosensitization as a Means to Augment Commercial Antifungal Agents
por: Campbell, Bruce C., et al.
Publicado: (2012)

Expression of DNA Damage Response Markers in Early-Onset or Familial Gastric Cancers
por: Kim, Hee Sung, et al.
Publicado: (2019)

The Protective Role of Exosome-Derived MicroRNAs and Proteins from Human Breast Milk against Infectious Agents
por: Kim, Ki-Uk, et al.
Publicado: (2023)

Meta-Analysis of ERCC1 Protein Expression and Platinum Chemosensitivity in Non-Small-Cell Lung Cancer
por: Li, Guoping, et al.
Publicado: (2020)

Estrogens Counteract Platinum-Chemosensitivity by Modifying the Subcellular Localization of MDM4
por: Lucà, Rossella, et al.
Publicado: (2019)

Ginseng, the natural effectual antiviral: Protective effects of Korean Red Ginseng against viral infection
por: Im, Kyungtaek, et al.
Publicado: (2016)

Graphene Oxide–Platinum Nanoparticle Nanocomposites: A Suitable Biocompatible Therapeutic Agent for Prostate Cancer
por: Gurunathan, Sangiliyandi, et al.
Publicado: (2019)

Editorial: Use of chemosensitization to augment efficacy of antifungal agents, Volume II
por: Kim, Jong H., et al.
Publicado: (2023)

Toward Better Predictions of Chemosensitivity: Comparative Study of Conventional and Simulated Chemosensitivity Tests for Bladder Cancer Cell Lines
por: Kim, Taek Sang, et al.
Publicado: (2017)

Molecular Subtypes and Tumor Microenvironment Characteristics of Small-Cell Lung Cancer Associated with Platinum-Resistance
por: Kim, Jihyun, et al.
Publicado: (2023)

Gastric cancer--the recognition of a chemosensitive tumour.
por: Cunningham, D.
Publicado: (1988)

Lycopene Inhibits Activation of Epidermal Growth Factor Receptor and Expression of Cyclooxygenase-2 in Gastric Cancer Cells
por: Han, Hwana, et al.
Publicado: (2019)

Prevalence of BRCA1 and BRCA2 Mutations in Korean Breast Cancer Patients
por: Ahn, Sei Hyun, et al.
Publicado: (2004)

Role of BRCA Mutations in the Modulation of Response to Platinum Therapy
por: Mylavarapu, Sanghamitra, et al.
Publicado: (2018)

Self-activated ultrahigh chemosensitivity of oxide thin film nanostructures for transparent sensors
por: Moon, Hi Gyu, et al.
Publicado: (2012)

The expression of ERCC1 and BRCA1 predicts prognosis of platinum-based chemotherapy in urothelial cancer
por: Song, Wenhui, et al.
Publicado: (2016)

Autophagy modulating agents as chemosensitizers for cisplatin therapy in cancer
por: Gąsiorkiewicz, Bartosz Mateusz, et al.
Publicado: (2020)

BRCA1 Promoter Hypermethylation is Associated with Good Prognosis and Chemosensitivity in Triple-Negative Breast Cancer
por: Jacot, William, et al.
Publicado: (2020)

Modulating Chemosensitivity of Tumors to Platinum-Based Antitumor Drugs by Transcriptional Regulation of Copper Homeostasis
por: Lai, Yu-Hsuan, et al.
Publicado: (2018)

Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation
por: Wattenberg, Max M., et al.
Publicado: (2019)

Inhibitory Effect of Astaxanthin on Gene Expression Changes in Helicobacter pylori-Infected Human Gastric Epithelial Cells
por: Kim, Suhn Hyung, et al.
Publicado: (2021)

Synthesis, Characterization, and Anticancer Activity of Benzothiazole Aniline Derivatives and Their Platinum (II) Complexes as New Chemotherapy Agents
por: Islam, Md. Kamrul, et al.
Publicado: (2021)

ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and/or docetaxel
por: Wang, Lifeng, et al.
Publicado: (2008)

Targeting the Oxidative Stress Response System of Fungi with Redox-Potent Chemosensitizing Agents
por: Kim, Jong H., et al.
Publicado: (2012)

miR-211 facilitates platinum chemosensitivity by blocking the DNA damage response (DDR) in ovarian cancer
por: Wang, Tianzhen, et al.
Publicado: (2019)

Comparisons of survival outcomes between bevacizumab and olaparib in BRCA-mutated, platinum-sensitive relapsed ovarian cancer: a Korean Gynecologic Oncology Group study (KGOG 3052)
por: Kim, Se Ik, et al.
Publicado: (2021)

Prognostic Factors of Second and Third Line Chemotherapy Using 5-FU with Platinum, Irinotecan, and Taxane for Advanced Gastric Cancer
por: Park, Ji Soo, et al.
Publicado: (2011)

BRCA1/2 Reversion Mutations in Patients Treated with Poly ADP-Ribose Polymerase (PARP) Inhibitors or Platinum Agents
por: Darabi, Sourat, et al.
Publicado: (2022)

Discovery of Myeloid-Derived Suppressor Cell-Specific Metabolism by Metabolomic and Lipidomic Profiling
por: Kim, Jisu, et al.
Publicado: (2023)

The association between chemosensitivity and Pgp, GST-π and Topo II expression in gastric cancer
por: Geng, Ming, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_s946chlujk1s2tg78bp709es05